Me’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the ...

We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...

The founder of 23andMe, Anne Wojcicki, has asked a judge to reopen an auction for the genetic testing company, saying she has ...

The founder of 23andMe has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...

On TipRanks, RGEN has a Strong Buy consensus based on 18 Buy, 2 Hold and 1 Sell rating. Its highest price target is $958. RGEN stock’s consensus price target is $803.42 implying an 32.71% upside ...

To help our clients and readers sort through the volume of privacy, cyber, and AI news, we are switching Privacy, Cyber, & AI ...